Praxis Spinal Cord Institute is thrilled to welcome three cutting-edge technologies to their SCI Incubate program for 2023 — Battelle, inContAlert, and Focal Lines Technologies [supported under the SCI Validate program]. These innovators will spend four months honing their ideas and products to bring life-changing solutions to the spinal cord injury (SCI) community. Join us in celebrating this exciting opportunity to speed up the development of transformative technologies!
Following an international search for new and innovative treatments for spinal cord injury, a panel of experts selected three groundbreaking companies to develop care- and cure-related treatments that could revolutionize healthcare outcomes. The panel, which included people with lived experience of SCI (PLEX), researchers, and commercial leaders, chose the three companies based on their potential to transform the lives of people with SCI.
The SCI Incubate Program is the perfect opportunity for early-stage start-ups to take their care- and cure-related treatments to the next level. As part of the Praxis Commercialization initiative, the four-month program provides invaluable mentorship and networking opportunities, as well as up to $20K CAD in targeted funding to help reach set objectives. Take advantage of this unique chance to improve the quality of life for people with SCI.
SCI Validate is an innovative program that offers early-stage support for cutting-edge projects, like Focal Lines Technologies. With a special emphasis on PLEX-based user testing, SCI Validate is helping to develop the pre-prototype technologies of the future. Be part of the cutting edge and join SCI Validate today!
SCI Incubate 2023 Cohort:
Battelle’s NeuroLife® wearable sleeve technology is revolutionizing the measurement of nerves and muscles in the forearm with its high-resolution, real-time capabilities. By providing targeted stimulation interventions, NeuroLife® enables the recreation of intricate and dexterous hand movements, revolutionizing the way we interact with our environment.
Incontinence patients can now be more in control of their condition thanks to IncontinContAlert. This revolutionary technology uses wearable sensors to unobtrusively monitor the bladder throughout the day. Advanced machine learning algorithms then create personalized alerts for when a predefined filling level is reached, so that patients can act before an accident occurs. With IncontinContAlert, incontinence patients can be more confident and proactive in managing their condition.
Focal Lines Technologies, based in Vancouver, BC, is revolutionizing the field of smart material development, remote health technology, and virtual care. By utilizing an advanced e-textile sensor system with novel nanomaterials, they are able to provide seamless connections and monitoring of patients remotely to provide smart rehabilitation insights that help individuals regain their independence. Supported by SCI Validate, Focal Lines Technologies is leading the way in healthcare innovation.
Praxis is deeply thankful to the Government of Canada, the Province of BC, and Genome BC for their generous contribution to SCI Incubate. This invaluable support is instrumental in helping us reach our goals and grow our program. We are immensely grateful for their ongoing commitment.
About Praxis Spinal Cord Institute
At the Praxis Spinal Cord Institute, we are dedicated to creating a world without paralysis after SCI. We are constantly pushing the boundaries of research and innovation, working in collaboration with international researchers, health care professionals, entrepreneurs, and investors to develop groundbreaking treatments and technologies. Our PLEX program is at the heart of this pioneering effort, providing a platform for clinical trials, capital, and cutting-edge ideas. Together, we will create a future in which SCI is no longer a barrier.
Based in beautiful Vancouver, BC, Canada, we are proud to bring together a global network of individuals with spinal cord injuries, and world-renowned experts, to work together to identify, prioritize and tackle the most pressing challenges. Our mission is to foster meaningful progress and meaningful change for those affected by SCI. Let’s make a difference together.
At SCI, our goal is to drive discovery and innovation in order to improve the quality of life for those affected by spinal cord injuries. We tackle this challenge with a multi-disciplinary, adaptive approach that ensures maximum impact. Through our efforts, we strive to accelerate progress and make a difference in the lives of those living with SCI.